CytoDyn CYDY
OTC CYDY
$0.23 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

CytoDyn (CYDY) Return on Equity [ROE] (2010 - 2020)

Updated

CytoDyn's Return on Equity [ROE] was -107737.98% in fiscal Q1 2021 (quarter ended Aug 31, 2020).

Analysis

CytoDyn (CYDY) Return on Equity [ROE] (2010 - 2020) Analysis & Trends

For FY2017 (ended May 31, 2017), Return on Equity [ROE] at CytoDyn came in at -566.10%.

  • Return on Equity [ROE] shows a three-year change of +106.17 percentage points (FY2014 to FY2017).
  • In earlier fiscal years, Return on Equity [ROE] was -672.27% in FY2014.
  • The fiscal Q1 2021 figure marks the highest quarterly Return on Equity [ROE] in data going back to fiscal Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 CytoDyn 334.50 Mn 285.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2020 -107,737.98%
May 31, 2017 -1,194.50%
Feb 28, 2017 -471.23%
Nov 30, 2016 -384.62%
Aug 31, 2016 -269.31%
May 31, 2016 -240.09%
Feb 29, 2016 -781.62%
Aug 31, 2014 -575.24%
May 31, 2014 -232.63%
Feb 28, 2014 -146.66%
Nov 30, 2013 -242.66%
Feb 28, 2013 -22,987.00%
Feb 28, 2011 50,933.75%
Nov 30, 2010 65,576.74%
API Access

CytoDyn Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CYDY&period=max&api_key=YOUR_API_KEY